Skip to main content
. 2023 Sep 27;31(1):154–164. doi: 10.1093/jamia/ocad186

Figure 5.

Figure 5.

Summary of Pharos data by disease cluster. (A) The number of gene targets with a TDL label from Pharos within each cluster, and (B) the number of drugs connected to each cluster through gene targets. Drugs were obtained from the Pharos based on their “Tclin” ligand readiness level assignment.